Ledger.Open graph →
SEC Form D · filed September 18, 2019

Front Range Biosciences, Inc

Offering
$8.5M
Sold
$8.5M
Exemption
Rule 506(b)
Industry
Other
Location
LAFAYETTE, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Ephraim Lindenbaum · Campbell, CADirectorJonathan Vaught · Lafayette, COExec · DirectorWilliam Militello · LAFAYETTE, CODirectorNicholas Hofmeister · San Diego, CAExec · DirectorEphraim Lindenbaum · Aurora, CODirectorJonathan Vaught · Lafayette, COExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗